105 related articles for article (PubMed ID: 11781134)
1. Diverse inhibitors of intracellular signalling act as adenosine receptor antagonists.
Schulte G; Fredholm BB
Cell Signal; 2002 Feb; 14(2):109-13. PubMed ID: 11781134
[TBL] [Abstract][Full Text] [Related]
2. Transducing system operated by adenosine A(2A) receptors to facilitate acetylcholine release in the rat hippocampus.
Rebola N; Oliveira CR; Cunha RA
Eur J Pharmacol; 2002 Nov; 454(1):31-8. PubMed ID: 12409002
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.
Lopes LV; Cunha RA; Kull B; Fredholm BB; Ribeiro JA
Neuroscience; 2002; 112(2):319-29. PubMed ID: 12044450
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein kinase B by the A(1)-adenosine receptor in DDT(1)MF-2 cells.
Germack R; Dickenson JM
Br J Pharmacol; 2000 Jun; 130(4):867-74. PubMed ID: 10864894
[TBL] [Abstract][Full Text] [Related]
5. GTP differentially affects antagonist radioligand binding to adenosine A(1) and A(2A) receptors in human brain.
Kull B; Svenningsson P; Hall H; Fredholm BB
Neuropharmacology; 2000 Sep; 39(12):2374-80. PubMed ID: 10974321
[TBL] [Abstract][Full Text] [Related]
6. Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus.
Sperlágh B; Zsilla G; Baranyi M; Illes P; Vizi ES
Neuroscience; 2007 Oct; 149(1):99-111. PubMed ID: 17850981
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory responses to exogenous adenosine in murine proximal and distal colon.
Zizzo MG; Mulè F; Serio R
Br J Pharmacol; 2006 Aug; 148(7):956-63. PubMed ID: 16847444
[TBL] [Abstract][Full Text] [Related]
8. A galpha(s) carboxyl-terminal peptide prevents G(s) activation by the A(2A) adenosine receptor.
Mazzoni MR; Taddei S; Giusti L; Rovero P; Galoppini C; D'Ursi A; Albrizio S; Triolo A; Novellino E; Greco G; Lucacchini A; Hamm HE
Mol Pharmacol; 2000 Jul; 58(1):226-36. PubMed ID: 10860945
[TBL] [Abstract][Full Text] [Related]
9. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
Varani K; Merighi S; Gessi S; Klotz KN; Leung E; Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Borea PA
Mol Pharmacol; 2000 May; 57(5):968-75. PubMed ID: 10779381
[TBL] [Abstract][Full Text] [Related]
10. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.
Rossowski WJ; Cheng BL; Taylor JE; Datta R; Coy DH
Eur J Pharmacol; 2002 Mar; 438(3):159-70. PubMed ID: 11909607
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A2A receptors regulate the extracellular accumulation of excitatory amino acids upon metabolic dysfunction in chick cultured retinal cells.
Rego AC; Agostinho P; Melo J; Cunha RA; Oliveira CR
Exp Eye Res; 2000 May; 70(5):577-87. PubMed ID: 10870516
[TBL] [Abstract][Full Text] [Related]
12. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
Robinson AJ; Dickenson JM
Eur J Pharmacol; 2001 Feb; 413(2-3):151-61. PubMed ID: 11226388
[TBL] [Abstract][Full Text] [Related]
13. Facilitation of noradrenaline release by activation of adenosine A(2A) receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery.
Fresco P; Diniz C; Gonçalves J
Cardiovasc Res; 2004 Sep; 63(4):739-46. PubMed ID: 15306230
[TBL] [Abstract][Full Text] [Related]
14. Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats.
Lopes LV; Cunha RA; Ribeiro JA
J Neurophysiol; 1999 Dec; 82(6):3196-203. PubMed ID: 10601453
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A(2A) and A(2B) receptor activation of erythropoietin production.
Fisher JW; Brookins J
Am J Physiol Renal Physiol; 2001 Nov; 281(5):F826-32. PubMed ID: 11592940
[TBL] [Abstract][Full Text] [Related]
16. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
18. Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
Smith AD; Cheek DJ; Buxton IL; Westfall DP
Clin Exp Pharmacol Physiol; 1997 Jul; 24(7):492-7. PubMed ID: 9248666
[TBL] [Abstract][Full Text] [Related]
19. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
Prentice DJ; Hourani SM
Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
